CORT Q4 2021 Earnings — Corcept Therapeutics Incorporated Revenue & Financial Results | Market Cap Arena

CORTCorcept Therapeutics Incorporated

$4B

Q4 2021 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$99M+15.3% YoY

Gross Profit

$97M98.6% margin

Operating Income

$37M37.1% margin

Net Income

$32M32.4% margin

EPS (Diluted)

$0.26

QoQ Revenue Growth

+2.8%

Cash Flow

Operating Cash Flow

$49M

Free Cash Flow

$49M

Stock-Based Comp.

$11M

Balance Sheet

Total Assets

$424M

Total Liabilities

$48M

Stockholders' Equity

$376M

Cash & Equivalents

$78M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$99M	$86M	+15.3%
Gross Profit	$97M	$84M	+15.4%
Operating Income	$37M	$31M	+20.2%
Net Income	$32M	$26M	+23.3%